Clinical Program Operations Manager, Therapeutics & Innovations
Natera- Full Time
- Senior (5 to 8 years)
The Associate Director of Site Profiling & Institutional Insights should possess a Bachelor’s degree in a relevant field, such as Business, Marketing, Healthcare Administration, or a related discipline, and have at least 7 years of experience in market access, commercial operations, or a similar role within the biotechnology or pharmaceutical industry. Strong analytical skills, including data interpretation and segmentation, are essential, along with experience in developing and implementing strategic plans. Experience with CRM systems and proficiency in Microsoft Office Suite are also required.
This role involves developing and managing a national profiling program to assess treatment center readiness, create tailored activation plans, and provide actionable insights to field teams. The Associate Director will lead data collection through surveys and interviews, segment treatment centers, and collaborate with Market Enablement to translate profiles into onboarding playbooks. They will also integrate field strategy with sales and marketing, deliver comprehensive site intelligence, contribute to forecasting, and monitor institutional adoption curves, ensuring ongoing operational readiness and supporting the successful launch of ORCA-T.
Develops and commercializes cell therapies
Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.